| Journal | The International journal on drug policy |
| Study Type | Cohort |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
Rapidly changing cannabis legalization has contributed to increased cannabis use and co-use of cannabis and alcohol, including among sexual and gender minority people (SGM). Black SGM endure long-standing disparities in comorbidities of substance use, mental health, and other critical health outcomes, yet little is known about cannabis-alcohol co-use and its mental health correlates. This study examined associations of anxiety/depression symptoms with same-day cannabis-alcohol co-use among Black SGM. Data were obtained from the Neighborhoods and Networks Part 2 (N2P2) Study (2022-2024), a cohort of Black SGM aged 16-35 in Chicago, Illinois (n = 617). Participants completed a 14-day ecological momentary assessment (EMA) of cannabis and alcohol use and mental health symptoms. Random-effect multinomial logistic regression models examined relationships of anxiety/depression and same-day cannabis-alcohol co-use. Across 5729 EMA days from 521 participants who completed ≥1 EMA daily survey, s
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This study item was assembled from normalized source metadata and pipeline scoring.
